Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report released on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, Maxim Group raised shares of Galmed Pharmaceuticals from a hold rating to a buy rating in a research report on Monday, July 24th. View […]
More Stories
Kavango Resources (LON:KAV) Shares Up 15.3% – Still a Buy?
Kavango Resources Plc (LON:KAV – Get Free Report)’s stock price shot up 15.3% on Monday . The stock traded as...
Highland Copper (CVE:HI) Stock Price Down 17.6% – Time to Sell?
Shares of Highland Copper Company Inc. (CVE:HI – Get Free Report) fell 17.6% on Monday . The stock traded as...
Highland Copper (CVE:HI) Trading Down 17.6% – What’s Next?
Highland Copper Company Inc. (CVE:HI – Get Free Report)’s stock price fell 17.6% on Monday . The company traded as...
National Research Co. (NRC) To Go Ex-Dividend on December 27th
National Research Co. (NASDAQ:NRC – Get Free Report) announced a quarterly dividend on Friday, October 25th,Zacks Dividends reports. Stockholders of...
Directa Plus (LON:DCTA) Sets New 52-Week Low – What’s Next?
Directa Plus Plc (LON:DCTA – Get Free Report) shares hit a new 52-week low on Monday . The stock traded...
Marwyn Value Investors (LON:MVI) Reaches New 1-Year High – Should You Buy?
Marwyn Value Investors (LON:MVI – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday...